Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 11325 | 990 | 24.5 | 47% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
| 233 | 3 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//FLUOROQUINOLONES | 48717 |
| 451 | 2 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//CHEMOTHERAPY-TOKYO | 16125 |
| 11325 | 1 | CLASS I BETA LACTAMASE//JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//2 KETO 3 DEOXY OCTONATE | 990 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | CLASS I BETA LACTAMASE | authKW | 61685 | 0% | 100% | 2 |
| 2 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | journal | 59475 | 16% | 1% | 155 |
| 3 | 2 KETO 3 DEOXY OCTONATE | authKW | 30842 | 0% | 100% | 1 |
| 4 | 2 KETO 3 DEOXYOCTONATE CARBOHYDRATE RATIO | authKW | 30842 | 0% | 100% | 1 |
| 5 | 23 WADAI | address | 30842 | 0% | 100% | 1 |
| 6 | BETA LACTAMASE IDENTIFICATION | authKW | 30842 | 0% | 100% | 1 |
| 7 | BIOTIN BINDING PROTEINS | authKW | 30842 | 0% | 100% | 1 |
| 8 | BROAD SPECTRUM PLASMID MEDIATED BETA LACTAMASES | authKW | 30842 | 0% | 100% | 1 |
| 9 | C MAX MIC80 | authKW | 30842 | 0% | 100% | 1 |
| 10 | CEPHALINOSPORINASE | authKW | 30842 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Microbiology | 20060 | 59% | 0% | 583 |
| 2 | Infectious Diseases | 10053 | 30% | 0% | 299 |
| 3 | Pharmacology & Pharmacy | 7123 | 49% | 0% | 490 |
| 4 | Immunology | 485 | 12% | 0% | 121 |
| 5 | Pathology | 261 | 5% | 0% | 52 |
| 6 | Medicine, General & Internal | 213 | 8% | 0% | 83 |
| 7 | Biotechnology & Applied Microbiology | 110 | 6% | 0% | 59 |
| 8 | Oncology | 71 | 7% | 0% | 65 |
| 9 | Medicine, Research & Experimental | 4 | 2% | 0% | 20 |
| 10 | Chemistry, Medicinal | 3 | 1% | 0% | 13 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | 23 WADAI | 30842 | 0% | 100% | 1 |
| 2 | MED MICROBIOL IMMUNOL PATHOL ME | 30842 | 0% | 100% | 1 |
| 3 | MED PHARMACOL CHEMOTHER Y SECT | 30842 | 0% | 100% | 1 |
| 4 | NINEWELLS HOSP MED MED MICROBIOL | 30842 | 0% | 100% | 1 |
| 5 | SCOTTISH ANTIBIOT REFERENCE | 30842 | 0% | 100% | 1 |
| 6 | UFA ORGAN CHEM | 30842 | 0% | 100% | 1 |
| 7 | UNIDAD CIUDADOS INTENS PEDIAT | 30842 | 0% | 100% | 1 |
| 8 | CA ROMANZI DISCAT | 15420 | 0% | 50% | 1 |
| 9 | SHOWA UNIV HOSP | 6167 | 0% | 20% | 1 |
| 10 | ENVIRONM INFECT DIS | 4404 | 0% | 14% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 59475 | 16% | 1% | 155 |
| 2 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 27822 | 15% | 1% | 146 |
| 3 | CHEMOTHERAPY | 23515 | 4% | 2% | 44 |
| 4 | CHEMIOTERAPIA | 19410 | 2% | 4% | 15 |
| 5 | REVIEWS OF INFECTIOUS DISEASES | 11645 | 3% | 1% | 31 |
| 6 | PATHOLOGIE BIOLOGIE | 9169 | 4% | 1% | 36 |
| 7 | JOURNAL OF ANTIBIOTICS | 5963 | 4% | 1% | 36 |
| 8 | ACTA PATHOLOGICA MICROBIOLOGICA ET IMMUNOLOGICA SCANDINAVICA SECTION B-MICROBIOLOGY | 4919 | 1% | 2% | 8 |
| 9 | EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 4678 | 3% | 0% | 31 |
| 10 | IMMUNITAT UND INFEKTION | 4500 | 1% | 2% | 9 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | SANDERS, CC , (1987) CHROMOSOMAL CEPHALOSPORINASES RESPONSIBLE FOR MULTIPLE RESISTANCE TO NEWER BETA-LACTAM ANTIBIOTICS.ANNUAL REVIEW OF MICROBIOLOGY. VOL. 41. ISSUE . P. 573-593 | 69 | 67% | 138 |
| 2 | STAPLETON, P , SHANNON, K , PHILLIPS, I , (1995) THE ABILITY OF BETA-LACTAM ANTIBIOTICS TO SELECT MUTANTS WITH DEREPRESSED BETA-LACTAMASE SYNTHESIS FROM CITROBACTER-FREUNDII.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. VOL. 36. ISSUE 3. P. 483-496 | 25 | 81% | 17 |
| 3 | SANDERS, WE , SANDERS, CC , (1988) INDUCIBLE BETA-LACTAMASES - CLINICAL AND EPIDEMIOLOGIC IMPLICATIONS FOR USE OF NEWER CEPHALOSPORINS.REVIEWS OF INFECTIOUS DISEASES. VOL. 10. ISSUE 4. P. 830-838 | 27 | 66% | 144 |
| 4 | SANDERS, CC , SANDERS, WE , (1986) TYPE-I BETA-LACTAMASES OF GRAM-NEGATIVE BACTERIA - INTERACTIONS WITH BETA-LACTAM ANTIBIOTICS.JOURNAL OF INFECTIOUS DISEASES. VOL. 154. ISSUE 5. P. 792-800 | 25 | 81% | 126 |
| 5 | BARRIERE, SL , (1992) BACTERIAL-RESISTANCE TO BETA-LACTAMS, AND ITS PREVENTION WITH COMBINATION ANTIMICROBIAL THERAPY.PHARMACOTHERAPY. VOL. 12. ISSUE 5. P. 397-402 | 27 | 63% | 14 |
| 6 | LIVERMORE, DM , (1987) CLINICAL-SIGNIFICANCE OF BETA-LACTAMASE INDUCTION AND STABLE DEREPRESSION IN GRAM-NEGATIVE RODS.EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. VOL. 6. ISSUE 4. P. 439-445 | 22 | 79% | 153 |
| 7 | SANDERS, CC , SANDERS, WE , (1992) BETA-LACTAM RESISTANCE IN GRAM-NEGATIVE BACTERIA - GLOBAL TRENDS AND CLINICAL IMPACT.CLINICAL INFECTIOUS DISEASES. VOL. 15. ISSUE 5. P. 824-839 | 48 | 25% | 237 |
| 8 | WEISCHER, M , SCHUMACHER, H , KOLMOS, HJ , (1994) RESISTANCE CHARACTERISTICS OF BLOOD CULTURE ISOLATES OF ENTEROBACTER-CLOACAE WITH SPECIAL REFERENCE TO BETA-LACTAMASES AND RELATION TO PRECEDING ANTIMICROBIAL THERAPY.APMIS. VOL. 102. ISSUE 5. P. 356-366 | 22 | 61% | 5 |
| 9 | CURTIS, NAC , EISENSTADT, RL , RUDD, C , WHITE, AJ , (1986) INDUCIBLE TYPE-I BETA-LACTAMASES OF GRAM-NEGATIVE BACTERIA AND RESISTANCE TO BETA-LACTAM ANTIBIOTICS.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. VOL. 17. ISSUE 1. P. 51-61 | 18 | 100% | 68 |
| 10 | RAHME, C , BUTTERFIELD, JM , SCIENC, AMACOPH , LODISE, TP , (2014) DUAL BETA-LACTAM THERAPY FOR SERIOUS GRAM-NEGATIVE INFECTIONS: IS IT TIME TO REVISIT?.DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. VOL. 80. ISSUE 4. P. 239 -259 | 30 | 23% | 7 |
Classes with closest relation at Level 1 |